Compare First Citizens BancShares Inc (FCNCA) vs Johnson & Johnson (JNJ) Price & Performance

First Citizens BancShares (FCNCA) trades at $2,258.55, up 1.13% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a P/E of 12.08 and net income margin of 25.23%, supported by positive cash flow trends and strategic expansions in commercial banking services. Recent news highlights institutional investments and new leadership appointments, reinforcing growth initiatives.

Outlook remains favorable due to consistent earnings outperformance and expanding business segments, though risks include elevated uninsured deposits and net interest margin pressure. Analyst consensus is mixed with a hold-heavy rating, but the stock offers value with upside to the $2,310 price target. Investors should weigh solid profitability against sector-specific headwinds.

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.